Quality improvement guidelines for endovascular treatment of iliac artery occlusive disease
Dimitrios Tsetis1, Raman Uberoi
1Department of Radiology, University Hospital of Heraklion, Medical School of Crete, P.O. Box 1352, Stavrakia, 71110, Heraklion, Crete, Greece. tsetis@med.uoc.gr
Insights
Endovascular therapy is effective for iliac artery lesions, with stenting improving outcomes. Further research is needed to confirm optimal stenting strategies and antibiotic use.
Area of Science:
- Vascular Surgery
- Interventional Radiology
Background:
- Endovascular therapy is the primary treatment for Type A and preferred for Type B iliac artery lesions.
- It can be applied selectively for Type C and D lesions.
Purpose of the Study:
- To review the current applications and outcomes of endovascular therapy for iliac artery lesions.
- To discuss optimal stenting strategies and adjunctive therapies.
Main Methods:
- Review of endovascular techniques for iliac artery recanalization.
- Discussion of various access routes (femoral, brachial) and spaces (intraluminal, subintimal).
- Analysis of stent application, including primary vs. selective stenting and stent design considerations.
Main Results:
- Stenting has improved immediate hemodynamic and long-term clinical results in iliac percutaneous transluminal angioplasty.
- The superiority of primary over selective stenting is not yet proven.
- Evidence for routine use of covered stents is insufficient.
Conclusions:
- Endovascular therapy is a viable option for various iliac artery lesion types.
- Antiplatelet therapy is recommended post-procedure; antibiotic prophylaxis lacks consensus.
- Further evidence is needed to guide optimal stenting techniques and stent selection.
Abstract:
Endovascular therapy is the treatment of choice for type A and the preferred treatment for type B lesions. In selective patients, this type of treatment can be applied in type C and even type D lesions. Ipsilateral femoral, contralateral femoral, and brachial approach and both the intraluminal and subintimal space can be used for successful recanalization. The application of stents has improved the immediate hemodynamic and probably long-term clinical results of iliac percutaneous transluminal angioplasty. However, the superiority of primary or direct stenting over selective stenting has not been proven yet. The choice of stent type depends on lesion morphology and location but otherwise there is insufficient evidence to support the use of a particular stent design. There is insufficient evidence to justify routine use of covered stents. All patients should receive antiaggregant therapy following endovascular recanalization of iliac arteries. There is no consensus regarding prophylaxis with antibiotics in iliac recanalization procedures.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management
Aneurysm IV: Nursing Management

